PEPTAI Price Swings Wild As Base Integration Fuels DeSci Hype
The post PEPTAI Price Swings Wild As Base Integration Fuels DeSci Hype appeared first on Coinpedia Fintech News PEPTAI an decentralized science token exploded to nearly $2.50 on Dexscreener before crashing back toward $0.9033, all while AI-driven drug discovery narratives keep heating up across the market. And honestly, its not hard to see why attention suddenly flooded in. Autonomous Drug Discovery Narrative Gains Momentum The project centers around autonomous AI agents built for peptide drug discovery. Instead of relying on the painfully slow traditional pharmaceutical pipeline, PEPTAI claims its system can design novel peptide molecules within 24 hours while handling validation through a multi-stage computational pipeline. Well, the platform also uses blockchain infrastructure to secure intellectual property rights automatically. Thats the kind of “AI + crypto + biotech” crossover narrative it has. Moreover, according to todays announcement, autonomous agents are now live on Base, with each agent targeting a specific receptor and running continuously through a nine-gate validation process. The system also reportedly funds its own wet-lab experiments through x402 payment rails. Base Expansion Pushes PEPTAI Into Spotlight The Base integration appears to have amplified market interest rapidly. Demand surged shortly after the announcement from Bio Protocol highlighting the autonomous peptide discovery agents operating onchain. But lets be







